SEK13.98
1.13% today
Stockholm, Aug 28, 09:02 am CET
ISIN
SE0012570448
Symbol
OSSD

OssDsign Stock price

SEK14.14
-1.92 11.96% 1M
+1.08 8.27% 6M
+4.28 43.41% YTD
+6.43 83.40% 1Y
+9.38 197.06% 3Y
-3.86 21.44% 5Y
-3.24 18.64% 10Y
-3.24 18.64% 20Y
Stockholm, Closing price Wed, Aug 27 2025
-0.04 0.28%
ISIN
SE0012570448
Symbol
OSSD

Key metrics

Basic
Market capitalization
SEK1.6b
Enterprise Value
SEK1.4b
Net debt
positive
Cash
SEK212.7m
Shares outstanding
109.2m
Valuation (TTM | estimate)
P/E
negative | negative
P/S
9.3 | 8.2
EV/Sales
8.0 | 7.1
EV/FCF
negative
P/B
4.5
Financial Health
Equity Ratio
69.6%
Return on Equity
-23.2%
ROCE
-10.4%
ROIC
-20.4%
Debt/Equity
0.0
Financials (TTM | estimate)
Revenue
SEK168.2m | SEK190.5m
EBITDA
- | SEK-33.2m
EBIT
SEK-41.7m | SEK-38.0m
Net Income
SEK-45.7m | SEK-43.7m
Free Cash Flow
SEK-57.4m
Growth (TTM | estimate)
Revenue
36.2% | 42.2%
EBITDA
- | 25.3%
EBIT
43.9% | 20.9%
Net Income
59.8% | 12.0%
Free Cash Flow
35.9%
Margin (TTM | estimate)
Gross
96.7%
EBITDA
- | -17.4%
EBIT
-24.8%
Net
-27.2% | -22.9%
Free Cash Flow
-34.1%
More
EPS
SEK-0.5
FCF per Share
SEK-0.5
Short interest
-
Employees
31
Rev per Employee
SEK4.3m
Show more

Is OssDsign a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,011 stocks worldwide.

Financial data from OssDsign

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
168 168
36% 36%
100%
- Direct Costs 5.53 5.53
72% 72%
3%
163 163
57% 57%
97%
- Selling and Administrative Expenses 179 179
20% 20%
106%
- Research and Development Expense 23 23
10% 10%
14%
- -
-
-
- Depreciation and Amortization - -
-
-
EBIT (Operating Income) EBIT -42 -42
44% 44%
-25%
Net Profit -46 -46
60% 60%
-27%

In millions SEK.

Don't miss a Thing! We will send you all news about OssDsign directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

OssDsign AB is a holding company, which engages in the development and sales of medical technology products. The company is headquartered in Uppsala, Uppsala and currently employs 27 full-time employees. The company went IPO on 2019-05-24. The company aims at developing implantable products that respond to clinical challenges, with focus on bone healing. Its primary focus is skull surgery. The firm uses design solutions, material compositions and manufacturing processes mainly based on proprietary bioceramic technologies. The bioceramics it uses integrate with tissues and support bone ingrowth. OssDsign AB's main product is Craniomosaic, an implant for the repair of skull defects (cranioplasty). Along with it, the Company develops bioceramic implants for facial bone augmentation. The firm's customers include neurosurgeons, craniofacial and maxillofacial surgeons.

Head office Sweden
CEO Mr. Lundqvist
Employees 31
Website www.ossdsign.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today